During the past decade, Fundacion Cardiovascular Santa Maria conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacion Cardiovascular Santa Maria" are "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Fundacion Cardiovascular Santa Maria" in a lesser frequency.

Most popular intervention types in "Fundacion Cardiovascular Santa Maria" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Cardiovascular Santa Maria" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Cardiovascular Santa Maria". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundacion Cardiovascular Santa Maria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Cardiovascular Santa Maria, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".